Northern California Chapters

Sana’s Gene-Edited Islets Continue to Make Insulin Sana Biotechnology’s novel cell therapy approach uses gene editing to help transplanted islet…

Tzield Approved for Stage 3 T1D in the U.S. In an exciting update for the type 1 diabetes (T1D) community,…

We’re excited to introduce the distinguished speakers joining us at the 2026 Breakthrough T1D Community Summit: NorCal on August 29…